The new cap will apply to AstraZeneca’s entire range of inhaler products including Symbicort, Breztri Aerosphere, and Airsupra inhalers.
The new cap will apply to AstraZeneca’s entire range of inhaler products including Symbicort, Breztri Aerosphere, and Airsupra inhalers.